Oryzon Genomics SA (ES:ORY) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oryzon Genomics S.A. has announced the registration of the deed of execution for its capital increase via convertible bonds in the Commercial Registry of Madrid.
For further insights into ES:ORY stock, check out TipRanks’ Stock Analysis page.